{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T08:31:34Z","timestamp":1776760294961,"version":"3.51.2"},"reference-count":40,"publisher":"Japanese Society of Internal Medicine","issue":"17","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2023,9,1]]},"DOI":"10.2169\/internalmedicine.9774-22","type":"journal-article","created":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T22:12:48Z","timestamp":1675203168000},"page":"2539-2545","source":"Crossref","is-referenced-by-count":3,"title":["Intracranial Myeloid Sarcoma Mimicking Hypertensive Intracerebral Hemorrhage"],"prefix":"10.2169","volume":"62","author":[{"given":"Shuhei","family":"Ikeda","sequence":"first","affiliation":[{"name":"Division of Neurology, Department of Internal Medicine, Faculty of Medicine, Saga University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaomi","family":"Tsutsumi","sequence":"additional","affiliation":[{"name":"Division of Neurology, Department of Internal Medicine, Faculty of Medicine, Saga University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mai","family":"Fujita","sequence":"additional","affiliation":[{"name":"Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sho","family":"Okamoto","sequence":"additional","affiliation":[{"name":"Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Eriguchi","sequence":"additional","affiliation":[{"name":"Division of Neurology, Department of Internal Medicine, Faculty of Medicine, Saga University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Hara","sequence":"additional","affiliation":[{"name":"Division of Neurology, Department of Internal Medicine, Faculty of Medicine, Saga University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Pileri SA, Ascani S, Cox MC, et al. Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients. Leukemia 21: 340-350, 2007.","DOI":"10.1038\/sj.leu.2404491"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Neiman RS, Barcos M, Berard C, et al. Granulocytic sarcoma: a clinicopathologic study of 61 biopsied cases. Cancer 48: 1426-1437, 1981.","DOI":"10.1002\/1097-0142(19810915)48:6<1426::AID-CNCR2820480626>3.0.CO;2-G"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Clark WB, Strickland SA, Barrett AJ, Savani BN. Extramedullary relapses after allogeneic stem cell transplantation for acute myeloid leukemia and myelodysplastic syndrome. Haematologica 95: 860-863, 2010.","DOI":"10.3324\/haematol.2010.025890"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Shallis RM, Gale RP, Lazarus HM, et al. Myeloid sarcoma, chloroma, or extramedullary acute myeloid leukemia tumor: a tale of misnomers, controversy and the unresolved. Blood Rev 47: 100773, 2021.","DOI":"10.1016\/j.blre.2020.100773"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Chaudhry AA, Gul M, Chaudhry AA, Dunkin J. Qualitative assessment of diffusion weighted imaging and susceptibility weighted imaging of myeloid sarcoma involving the brain. J Comput Assist Tomogr 40: 61-66, 2016.","DOI":"10.1097\/RCT.0000000000000337"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. O&apos;Brien CE, Saratsis AM, Voyadzis JM. Granulocytic sarcoma in a patient with blast crisis mimicking a chronic subdural hematoma. J Clin Oncol 29: e569-e571, 2011.","DOI":"10.1200\/JCO.2010.33.1272"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Smidt MH, de Bruin HG, van&apos;t Veer MB, van den Bent MJ. Intracranial granulocytic sarcoma (chloroma) may mimic a subdural hematoma. J Neurol 252: 498-499, 2005.","DOI":"10.1007\/s00415-005-0680-8"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Gill AS, Gill R, Kaloostian P, et al. Intracranial myeloid sarcoma metastasis mimicking acute subdural hematoma. Case Rep Surg 2017: 3056285, 2017.","DOI":"10.1155\/2017\/3056285"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. McCabe MG, Broadbent V, Williams DM. Unusual cause of extradural haemorrhage. Med Pediatr Oncol 36: 654-656, 2001.","DOI":"10.1002\/mpo.1146"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Kabadi K, Anoop P, Sandhya V, Murthy GK. Intracranial granulocytic sarcoma as the first presentation of chronic myeloid leukemia in chronic phase. J Neurooncol 134: 473-474, 2017.","DOI":"10.1007\/s11060-017-2541-6"},{"key":"11","unstructured":"11. Ahn JY, Kwon SO, Shin MS, Kang SH, Kim YR. Meningeal chloroma (granulocytic sarcoma) in acute lymphoblastic leukemia mimicking a falx meningioma. J Neurooncol 60: 31-35, 2002."},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Yamauchi K, Yasuda M. Comparison in treatments of nonleukemic granulocytic sarcoma: report of two cases and a review of 72 cases in the literature. Cancer 94: 1739-1746, 2002.","DOI":"10.1002\/cncr.10399"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13. Tsimberidou AM, Kantarjian HM, Wen S, et al. Myeloid sarcoma is associated with superior event-free survival and overall survival compared with acute myeloid leukemia. Cancer 113: 1370-1378, 2008.","DOI":"10.1002\/cncr.23691"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14. Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 127: 2391-2405, 2016.","DOI":"10.1182\/blood-2016-03-643544"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Navi BB, Reichman JS, Berlin D, et al. Intracerebral and subarachnoid hemorrhaging in patients with cancer. Neurology 74: 494-501, 2010.","DOI":"10.1212\/WNL.0b013e3181cef837"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Singh A, Kumar P, Chandrashekhara SH, Kumar A. Unravelling chloroma: review of imaging findings. Br J Radiol 90: 20160710, 2017.","DOI":"10.1259\/bjr.20160710"},{"key":"17","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1186\/s12885-019-6357-y","volume":"19","author":"HJ Meyer","year":"2019","unstructured":"17. Meyer HJ, Ponisch W, Schmidt SA, et al. Clinical and imaging features of myeloid sarcoma: a German multicenter study. BMC Cancer 19: 1150, 2019.","journal-title":"BMC Cancer","ISSN":"https:\/\/id.crossref.org\/issn\/1471-2407","issn-type":"print"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Passarin MG, Vattemi E, Musso AM, et al. Intracranial granulocytic sarcoma after chemotherapy for pineal germinoma and testicular cancer. J Clin Oncol 26: 4507-4509, 2008.","DOI":"10.1200\/JCO.2008.17.0787"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Vinters HV, Gilbert JJ. Multifocal chloromas of the brain. Surg Neurol 17: 47-51, 1982.","DOI":"10.1016\/0090-3019(82)90042-8"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Singer OC, Sitzer M, du Mesnil de Rochemont R, Neumann-Haefelin T. Practical limitations of acute stroke MRI due to patient-related problems. Neurology 62: 1848-1849, 2004.","DOI":"10.1212\/01.WNL.0000125320.53244.FA"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Toyoda K, Yasaka M, Nagata K, et al.; the Bleeding with Antithrombotic Therapy (BAT) Study Group. Antithrombotic therapy influences location, enlargement, and mortality from intracerebral hemorrhaging. The Bleeding with Antithrombotic Therapy (BAT) Retrospective Study. Cerebrovasc Dis 27: 151-159, 2009.","DOI":"10.1159\/000177924"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Gotoh S, Hata J, Ninomiya T, et al. Trends in the incidence and survival of intracerebral hemorrhaging by its location in a Japanese community. Circ J 78: 403-409, 2014.","DOI":"10.1253\/circj.CJ-13-0811"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Pippard MJ, Callender ST, Sheldon PW. Infiltration of central nervous system in adult acute myeloid leukaemia. Br Med J 1: 227-229, 1979.","DOI":"10.1136\/bmj.1.6158.227"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Joselson RA, Beckstead JH, Davis RL. Granulocytic sarcoma of the brain after renal transplantation. J Neuropathol Exp Neurol 41: 580-587, 1982.","DOI":"10.1097\/00005072-198211000-00002"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Simpson TA Jr, Anderson ML, Garcia JH, Barton JC. Myeloblastoma of the brain. Acta Neuropathol 78: 444-447, 1989.","DOI":"10.1007\/BF00688182"},{"key":"26","unstructured":"26. Voessing R, Berthold F, Richard KE, Thun F, Schroeder R, Krueger GR. Primary myeloblastoma of the pineal region. Clin Neuropathol 11: 11-15, 1992."},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Kei PL, Kok TY, Linn YC, Padhy AK. Butterfly lesion of the corpus callosum: an unusual case of extramedullary myeloid sarcoma (granulocytic sarcoma). Clin Nucl Med 36: 365-366, 2011.","DOI":"10.1097\/RLU.0b013e31820aa1b4"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Olar A, Lapadat R, Davidson CJ, et al. Central nervous system involvement by myeloid sarcoma: a report of 12 cases and review of the literature. Clin Neuropathol 35: 314-325, 2016.","DOI":"10.5414\/NP300949"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Lee KH, Lee JH, Choi SJ, et al. Bone marrow <i>vs<\/i> extramedullary relapse of acute leukemia after allogeneic hematopoietic cell transplantation: risk factors and clinical course. Bone Marrow Transplant 32: 835-842, 2003.","DOI":"10.1038\/sj.bmt.1704223"},{"key":"30","doi-asserted-by":"publisher","unstructured":"30. Harris AC, Kitko CL, Couriel DR, et al. Extramedullary relapse of acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation: incidence, risk factors and outcomes. Haematologica 98: 179-184, 2013.","DOI":"10.3324\/haematol.2012.073189"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Ge L, Ye F, Mao X, et al. Extramedullary relapse of acute leukemia after allogeneic hematopoietic stem cell transplantation: different characteristics between acute myelogenous leukemia and acute lymphoblastic leukemia. Biol Blood Marrow Transplant 20: 1040-1047, 2014.","DOI":"10.1016\/j.bbmt.2014.03.030"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Alhashim N, Aljurf M, Hassanein M, et al. Extramedullary relapses after allogeneic stem cell transplantation for acute myeloid leukemia: clinical characteristics, incidence, risk factors and outcomes. Bone Marrow Transplant 53: 838-843, 2018.","DOI":"10.1038\/s41409-018-0093-9"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Yuda S, Fuji S, Onishi A, et al. Extramedullary relapse of acute myelogenous leukemia after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 25: 1152-1157, 2019.","DOI":"10.1016\/j.bbmt.2019.01.011"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Yoshihara S, Ikegame K, Kaida K, et al. Incidence of extramedullary relapse after haploidentical SCT for advanced AML\/myelodysplastic syndrome. Bone Marrow Transplant 47: 669-676, 2012.","DOI":"10.1038\/bmt.2011.163"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Solh M, DeFor TE, Weisdorf DJ, Kaufman DS. Extramedullary relapse of acute myelogenous leukemia after allogeneic hematopoietic stem cell transplantation: better prognosis than systemic relapse. Biol Blood Marrow Transplant 18: 106-112, 2012.","DOI":"10.1016\/j.bbmt.2011.05.023"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Oshima K, Kanda Y, Yamashita T, et al. Central nervous system relapse of leukemia after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 14: 1100-1107, 2008.","DOI":"10.1016\/j.bbmt.2008.07.002"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Frietsch JJ, Hunstig F, Wittke C, et al. Extra-medullary recurrence of myeloid leukemia as myeloid sarcoma after allogeneic stem cell transplantation: impact of conditioning intensity. Bone Marrow Transplant 56: 101-109, 2021.","DOI":"10.1038\/s41409-020-0984-4"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Almond LM, Charalampakis M, Ford SJ, Gourevitch D, Desai A. Myeloid sarcoma: presentation, diagnosis, and treatment. Clin Lymphoma Myeloma Leuk 17: 263-267, 2017.","DOI":"10.1016\/j.clml.2017.02.027"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Kwon M, Martinez-Laperche C, Infante M, et al. Evaluation of minimal residual disease by real-time quantitative PCR of Wilms&apos; tumor 1 expression in patients with acute myelogenous leukemia after allogeneic stem cell transplantation: correlation with flow cytometry and chimerism. Biol Blood Marrow Transplant 18: 1235-1242, 2012.","DOI":"10.1016\/j.bbmt.2012.01.012"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Ino K, Fuji S, Tajima K, et al. Clinical utility of Wilms&apos; tumor 1 monitoring in patients with myeloid malignancy and prior allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 23: 1780-1787, 2017.","DOI":"10.1016\/j.bbmt.2017.06.007"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/17\/62_9774-22\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T03:33:29Z","timestamp":1693625609000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/17\/62_9774-22\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,1]]},"references-count":40,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.9774-22","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,1]]},"article-number":"9774-22"}}